Screener
Harmony Biosciences Holdings, Inc. HRMY Total Cost of Revenue
Total Cost of Revenue at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Harmony Biosciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The source filing: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 8:16 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056720
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Net product revenue | $215,387 | $184,733 |
| Cost of product sold | 44,512 | 31,994 |
| Gross profit | 170,875 | 152,739 |
| Operating expenses: | ||
| Research and development | 69,383 | 34,540 |
| Sales and marketing | 31,694 | 30,711 |
| General and administrative | 32,507 | 31,243 |
| Total operating expenses | 133,584 | 96,494 |
Item 1. Financial Statements
FAQ
- What is Harmony Biosciences Holdings, Inc.'s total cost of revenue?
- Harmony Biosciences Holdings, Inc. (HRMY) reported total cost of revenue of $44.51M in Q1 2026.
- How has Harmony Biosciences Holdings, Inc.'s total cost of revenue changed year-over-year?
- Harmony Biosciences Holdings, Inc.'s total cost of revenue increased by 39.1% year-over-year, from $31.99M to $44.51M.
- What is the long-term trend for Harmony Biosciences Holdings, Inc.'s total cost of revenue?
- Over 4 years (2021 to 2025), Harmony Biosciences Holdings, Inc.'s total cost of revenue has grown at a 37.5% compound annual growth rate (CAGR), from $55.52M to $198.34M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.
Ask your AI about Harmony Biosciences Holdings, Inc.'s total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude